CRISPR
systems mediate adaptive immunity in bacteria and archaea
through diverse effector mechanisms and have been repurposed for versatile
applications in therapeutics and diagnostics thanks to their facile
reprogramming with RNA guides. RNA-guided CRISPR-Cas targeting and
interference are mediated by effectors that are either components
of multisubunit complexes in class 1 systems or multidomain single-effector
proteins in class 2. The compact class 2 CRISPR systems have been
broadly adopted for multiple applications, especially genome editing,
leading to a transformation of the molecular biology and biotechnology
toolkit. The diversity of class 2 effector enzymes, initially limited
to the Cas9 nuclease, was substantially expanded via computational
genome and metagenome mining to include numerous variants of Cas12
and Cas13, providing substrates for the development of versatile,
orthogonal molecular tools. Characterization of these diverse CRISPR
effectors uncovered many new features, including distinct protospacer
adjacent motifs (PAMs) that expand the targeting space, improved editing
specificity, RNA rather than DNA targeting, smaller crRNAs, staggered
and blunt end cuts, miniature enzymes, promiscuous RNA and DNA cleavage,
etc. These unique properties enabled multiple applications, such as
harnessing the promiscuous RNase activity of the type VI effector,
Cas13, for supersensitive nucleic acid detection. class 1 CRISPR systems
have been adopted for genome editing, as well, despite the challenge
of expressing and delivering the multiprotein class 1 effectors. The
rich diversity of CRISPR enzymes led to rapid maturation of the genome
editing toolbox, with capabilities such as gene knockout, base editing,
prime editing, gene insertion, DNA imaging, epigenetic modulation,
transcriptional modulation, and RNA editing. Combined with rational
design and engineering of the effector proteins and associated RNAs,
the natural diversity of CRISPR and related bacterial RNA-guided systems
provides a vast resource for expanding the repertoire of tools for
molecular biology and biotechnology.